Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

towfiqu-barbhuiya-6f2mpewg2ra-unsplash

FDA publishes report stating Global Pharma’s eye drops broke safety norms

April 4, 2023 Medical Communications

The FDA has published a report revealing that Global Pharma’s plant in India’s Chennai city failed to achieve safety norms …
News
james-yarema-5tymgag0wro-unsplash_1

InnoCare announced first subject dosed in clinical trial of novel targeted protein degrader ICP-490

April 4, 2023 Medical Communications

InnoCare has announced that the first subject has been dosed in its clinical trial of its novel targeted protein degrader …
News

Merck receives FDA approval for Keytruda in combination with Padcev to treat bladder cancer

April 4, 2023 Medical Communications

Merck (known as MSD globally) has announced that it has received FDA approval for Keytruda in combination with Padcev for …
News
david-travis-avvzjc0ynbq-unsplash_1

Pixium Vision’s Prima System granted FDA Breakthrough Device Designation

April 3, 2023 Medical Communications

French bioelectronics company Pixium Vision has been granted Breakthrough Device Designation by the FDA for its Prima System.   Prima …
News
pawel-czerwinski-kxblpqfyc9e-unsplash

AstraZeneca’s NMOSD treatment recommended marketing authorisation by CHMP

April 3, 2023 Medical Communications

Pharma giant AstraZeneca has been given a recommendation by the EU’s Committee for Medicinal Products (CHMP) for marketing authorisation for …
News

Abbott gains FDA approval for Epic Max tissue valve for the treatment of aortic valve disease

March 31, 2023 Medical Communications

Abbott has announced that the FDA has approved its Epic Max stented tissue valve to treat patients with aortic regurgitation …
News

First over-the-counter opioid overdose treatment approved by FDA

March 31, 2023 Medical Communications

The FDA has announced that it has approve Narcan, 4mg naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use. This …
News

NEC streamlines AI drug development with subsidiary reshuffle

March 31, 2023 Medical Communications

Japan-based NEC Corporation has announced that it is realigning its subsidiaries in order to streamline its AI drug development services. …
News

Nanoscope Therapeutics announces positive results from phase 2b trial in Retinitis Pigmentosa

March 31, 2023 Medical Communications

US-based Nanoscope Therapeutics has announced topline results from its phase 2b RESTORE clinical trial. Currently, patients with vision loss due …
News

Hovione and Laxxon Medical sign partnership over 3D printed pharmaceutical applications

March 30, 2023 Medical Communications

Hovione, a CDMO, and Laxxon Medical, a pharma-technology company, have signed a strategic partnership deal to bring 3D printing technologies …
News

Genialis raises $13m in Series A funding for the development of AI/ML patient classifiers

March 29, 2023 Medical Communications

Genialis, a computational precision medicine company, has announced that it’s raised more than $13m in Series A funding, co-led by …
News

University of Dundee aids AI research for hypertension

March 29, 2023 Medical Communications

The University of Dundee has announced its involvement in a Europe-wide project which will study whether AI can improve the …
News

OctoVent and Orient EuroPharma sign licensing agreement over immunotherapeutic candidate

March 28, 2023 Medical Communications

OctoVent, subsidiary of Hepalink Pharmaceutical Group, has entered into a license agreement with Taiwan-based Orient EuroPharma (OEP). The two companies …
News

Abberior installs new STED microscope at MBC BioLabs

March 27, 2023 Medical Communications

Abberior has announced that it has placed a super-resolution STED microscope at MBC BioLabs, which is the leading San Francisco …
News

FDA releases draft of accelerated approval guidance for oncology therapeutics

March 27, 2023 Medical Communications

The FDA has released a draft of new guidance for accelerated approval for oncology therapeutics, highlighting the need for stricter …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025